Effect of Long Term α-Lipoic Acid Treatment on Endothelial Function in Patients With Type 2 Diabetes
NCT00490867 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2018-03-20
Summary
In the present study, endothelium dependent vasodilation will be induced by administration of acetylcholine (ACh). To ascertain whether the vascular effects, if any, of α-lipoic acid are limited to the endothelium, endothelium independent vasodilation will also be assessed by administration of glyceroltrinitrate (GTN).
Study objectives To investigate the effect of α-lipoic acid therapy on endothelium dependent and independent vasodilation, assessed by forearm blood flow (FBF), in patients with type 2 diabetes mellitus
Study design
Randomized, double-blinded, parallel group study for 23 days:
Day 1: FBF responses to acetylcholine and glyceroltrinitrate Day 2-22: intravenous infusion of 600 mg α-lipoic acid or placebo Day 23: FBF responses to acetylcholine and glyceroltrinitrate
Study population 30 subjects with type 2 diabetes
Study medication Acetylcholine (ACh) - intraarterial infusion, 25, 50, 100 nmol/min, infusion period 3 minutes/dose level Glyceroltrinitrate (GTN) - intraarterial infusion, 4, 8, 16 nmol/min, infusion period 3 minutes/dose level α-lipoic acid - intravenous infusion of 600 mg in 250 ml saline solution over 30 minutes
Main outcome variables Forearm blood flow (Ratio between intervention and control arm) Additional outcome variables Arterial blood pressure, pulse rate, markers of inflammation and oxidative stress, Insulin plasma levels, Glucose plasma levels
Risk/benefit assessment The insertion of intravenous cannula may cause mild and transient pain. A minor hematoma may occur at the site of cannula insertion. The insertion of the intraarterial cannula is performed under local anaesthesia and causes mild pain. The meassurement of forearm bloodflow, espacialy the wrist cuff (\>200 mmHG) may be uncomfortably. Local administration of drugs through a needle in the brachial artery allows the study of direct vascular effects of the drugs. Drug doses are 100 to 1000 times lower than a systemic effective dose, therefore no systemic adverse events are expected. There is experience in brachial artery infusions at our institution, and it is considered a safe technique. α-lipoic acid was well tolerated in healthy volunteers and subjects with diabetes at doses up to 600 mg intravenously and 1800 mg orally with side effects comparable with placebo. Altogether 50 ml blood will be collected throughout the study.
Conditions
Interventions
- DRUG
-
Alpha lipoic acid
Sponsors & Collaborators
-
Medical University of Vienna
lead OTHER
Principal Investigators
-
Michael Wolzt, MD · Clinical Pharmacology - Medical University Vienna
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 40 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-07-31
- Completion
- 2007-08-31
More Related Trials
-
Type 2 Diabetes Treatment and Remission With a Very Low-Calorie Ketogenic Diet (VLCKD) and Lifestyle Changes
NCT05984459 ·Status: COMPLETED
-
Alpha-lipoic Acid in Diabetic Patients With Ischemic Cardiomyopathy
NCT06056687 ·Status: COMPLETED ·Phase: NA
-
Impact of Alpha-Lipoic Acid Ingestion on Glucose Tolerance in Subjects With Pre-Diabetes
NCT03612037 ·Status: COMPLETED ·Phase: NA
-
Comparison of Nutritional Products for People With Type 2 Diabetes
NCT00797069 ·Status: COMPLETED ·Phase: PHASE3
-
Vinegar Co-ingestion in Type 2 Diabetes
NCT01279317 ·Status: COMPLETED ·Phase: NA
-
Study of the Effects of Vitamin C on Patients With Type 2 Diabetes
NCT00001870 ·Status: COMPLETED ·Phase: PHASE2
-
Determinants of Alpha-aminoadipic Acid (2-AAA) and Relationship to Diabetes: Study 3
NCT05210504 ·Status: COMPLETED ·Phase: PHASE1
-
n-3 Fatty Acid Infusion and Type 2 Diabetes
NCT00829569 ·Status: COMPLETED ·Phase: NA
-
Effects of 5-Aminolevulinic Acid on Glucose Metabolism
NCT01610778 ·Status: COMPLETED ·Phase: NA
-
Acetylcarnitine and Insulin Sensitivity
NCT00393770 ·Status: COMPLETED ·Phase: PHASE2
-
Carnitine Supplementation in Type 2 Diabetic Patients
NCT03230812 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of the Combination of Ten Elements for 6 Months in Patients With Diabetic Neuropathy : A Pilot Study
NCT05984771 ·Status: COMPLETED ·Phase: NA
-
Vitamin D and Painful Diabetic Neuropathy
NCT05080530 ·Status: UNKNOWN ·Phase: NA
-
Study to Determine the Effect of Synbiotics in Patients With Pre-diabetes
NCT04428606 ·Status: COMPLETED ·Phase: NA
-
Metabolic Effects of Stevia in Type 2 Diabetic Patients
NCT02834715 ·Status: COMPLETED ·Phase: NA
-
Effect of L-Citrulline Supplementation on Arginase Activity and Vascular Function in Diabetes
NCT03358264 ·Status: UNKNOWN ·Phase: NA
-
Effects of Vitamin D on Beta Cell Function and Insulin Sensitivity in Pre-diabetes and Diabetes Mellitus Type 2
NCT01497132 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of γ-linolenic Acid and Thioctic Acid in Patients With Diabetic Neuropathy
NCT03914404 ·Status: COMPLETED ·Phase: PHASE4
-
Alpha Lipoic Acid and Insulin Resistance
NCT00845156 ·Status: COMPLETED ·Phase: NA
-
Role of BCAA in Glucose Homeostasis
NCT05836350 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Impact of Acarbose on Abnormal Glucose Regulation in Patients With Coronary Artery Disease (AAA Trial)
NCT00858676 ·Status: UNKNOWN ·Phase: PHASE4
-
Effects of Food Advanced Glycation Endproducts on Vascular Function in Diabetes
NCT01456026 ·Status: COMPLETED ·Phase: NA
-
Effect of Nutritional Products in Subjects With Type 2 Diabetes
NCT02923960 ·Status: COMPLETED ·Phase: NA
-
Welchol as Monotherapy for Type 2 Diabetes Mellitus
NCT00789737 ·Status: COMPLETED ·Phase: PHASE3
-
AI(I)DA Acarbose and the Subclinical Inflammation
NCT00558883 ·Status: COMPLETED ·Phase: PHASE3